Sort
64,565 grants matching “drug discovery”
Pharmacogenomics of Childhood Leukemia ALL
$726,540William E. Evans · St. Jude Children'S Research Hospital · R01 · FY2017 · CA
Pharmacogenomics of Childhood Leukemia ALL
$726,520William E. Evans · St. Jude Children'S Research Hospital · R01 · FY2018 · CA
BIODIVERSITY CONSERVATION &DRUG DISCOVERY IN MADAGASCAR
$726,469Virginia Polytechnic Inst And St Univ · U01 · FY2004 · TW
BIODIVERSITY CONSERVATION &DRUG DISCOVERY IN MADAGASCAR
$726,467Virginia Polytechnic Inst And St Univ · U01 · FY2005 · TW
Salmonella-specific therapeutics
$726,417Brian M Ahmer · Ohio State University · R01 · FY2018 · AI
In silico safety pharmacology
$726,367Colleen E Clancy · University Of California At Davis · R01 · FY2023 · HL
Nanoscale Approaches to Understanding Membrane Protein Function
$726,327Stephen G. Sligar · University Of Illinois At Urbana-Champaign · R35 · FY2021 · GM
Tailoring Novel Therapeutics for Emerging Drug-Resistant C. Difficile Colitis
$726,199Richard L Guerrant · University Of Virginia · U01 · FY2010 · AI
From microcin sequence to function: linking sequence variation to antimicrobial activity
$726,176Bryan William Davies · University Of Texas At Austin · R56 · FY2024 · AI
CF Corrector Ligands Discovered on CF Human Airway Cells
$726,158Erik Mills Schwiebert · Discoverybiomed, Inc. · R44 · FY2011 · DK
Lead Optimization of Novel Inhibitors of Tissue Non-specific Alkaline Phosphatase
$726,119Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · AG
Defining the CD4 T Cell Response to Immunization with GAD
$726,039Helena Kristiina Reijonen · Benaroya Research Inst At Virginia Mason · DP3 · FY2012 · DK
Massively Parallel Identification of Protein Ligands
$726,031Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2013 · GM
Dopaminergic and Muscarinic Signaling in the Striatum
$726,002Dalton James Surmeier · Northwestern University At Chicago · R37 · FY2025 · NS
Variation in platelet function: the genetics of platelet gene expression
$725,979Paul F. Bray · Thomas Jefferson University · R01 · FY2012 · HL
Synthesis and Study of Natural and Non-natural Antiproliferative Agents
$725,971Andrew G Myers · Harvard University · R01 · FY2019 · CA
Re-engineering gp120 to include glycan-dependent epitopes
$725,929Phillip Berman · University Of California Santa Cruz · R01 · FY2016 · AI
Career Development and Training Program
$725,889David H Walker · University Of Texas Med Br Galveston · U54 · FY2011 · AI
High-throughput Functional Analysis of Autism Risk Genes
$725,870Ellen J Hoffman · Yale University · R01 · FY2024 · MH
PRECLINICAL MEDICATIONS DISCOVERY & ABUSE LIABILITY TESTING FOR NIDA
$725,804Louis S. Harris · Virginia Commonwealth University · N01 · FY2013 · DA
Emetine for SARS-CoV-2
$725,728Mark Henderson · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
3D Bioprinted skin models for drug screening
$725,728Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
3D Bioprinted Omentum tissue to model ovarian cancer metastasis
$725,728Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
3D Bioprinted lung cancer models for drug screening
$725,727Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Discovery and Assessment of Genetic Determinants of HCV and HIV Control
$725,722Raymond T Chung · Massachusetts General Hospital · R01 · FY2011 · DA